C. Chiodoni

发表

SPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage.

M. Colombo, S. Piconese, C. Tripodo, 2011, The American journal of pathology.

Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment

M. Ladomery, M. Colombo, M. Iezzi, 2019, Cellular Oncology.

Suppression of Invasion and Metastasis of Triple-Negative Breast Cancer Lines by Pharmacological or Genetic Inhibition of Slug Activity

M. Colombo, B. Calabretta, A. R. Soliera, 2014, Neoplasia.

Inhibiting interactions of lysine demethylase LSD1 with snail/slug blocks cancer cell invasion.

M. Colombo, B. Calabretta, A. R. Soliera, 2013, Cancer research.

Snail / Slug-LSD 1 interaction inhibition and invasion arrest 1 Inhibiting interactions of lysine demethylase LSD 1 with Snail / Slug blocks cancer cell invasion Running Title : Inhibition of Snail / Slug-LSD 1 interaction and invasion

M. Colombo, B. Calabretta, A. R. Soliera, 2012 .

Molecular and Cellular Pathobiology Inhibiting Interactions of Lysine Demethylase LSD 1 with Snail / Slug Blocks Cancer Cell Invasion

M. Colombo, B. Calabretta, A. R. Soliera, 2012 .

IFN‐γ‐independent synergistic effects of IL‐12 and IL‐15 induce anti‐tumor immune responses in syngeneic mice

P. Musiani, M. Colombo, S. Ferrini, 2002, European journal of immunology.

Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells

P. Lollini, M. Colombo, T. Myers, 2014, Growth factors.

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

M. Colombo, M. Rodolfo, C. Chiodoni, 1996, The Journal of experimental medicine.

Dendritic Cells Infiltrating Tumors Cotransduced with Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf) and Cd40 Ligand Genes Take up and Present Endogenous Tumor-Associated Antigens, and Prime Naive Mice for a Cytotoxic T Lymphocyte Response

M. Colombo, A. Stoppacciaro, M. Rodolfo, 1999, The Journal of experimental medicine.

Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity.

M. Colombo, G. Forni, C. Melani, 2003, Blood.

Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity.

M. Colombo, C. Tripodo, S. Sangaletti, 2016, Cell reports.

Mesenchymal Transition o f High-Grade Breast CarcinomasDepends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity Graphical

M. Colombo, C. Tripodo, S. Sangaletti, 2022 .

IL-1alpha gene-transfected human melanoma cells increase tumor-cell adhesion to endothelial cells and their retention in the lung of nude mice.

P. Musiani, S. Bernasconi, M. Colombo, 1996, International journal of cancer.

Transcriptional profiles and stromal changes reveal bone marrow adaptation to early breast cancer in association with deregulated circulating microRNAs.

M. Colombo, M. Dugo, C. Tripodo, 2019, Cancer research.

The ins and outs of osteopontin

M. Colombo, C. Tripodo, S. Sangaletti, 2015, Oncoimmunology.

OSTEOPONTIN SHAPES IMMUNE SUPPRESSION IN THE METASTATIC NICHE

C. Tripodo, S. Sangaletti, C. Chiodoni, 2014 .

Osteopontin shapes immunosuppression in the metastatic niche.

M. Colombo, C. Tripodo, S. Sangaletti, 2014, Cancer research.

Microenvironment and Immunology Osteopontin Shapes Immunosuppression in the Metastatic Niche

M. Colombo, C. Tripodo, S. Sangaletti, 2014 .

Intra-tumor heterogeneity of Diffuse Large B-cell Lymphoma involves the induction of diversified stroma-tumor interfaces

M. Colombo, C. Tripodo, M. Ponzoni, 2020, bioRxiv.

Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces

M. Colombo, C. Tripodo, M. Ponzoni, 2020, EBioMedicine.

cIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cells

M. Colombo, L. De Cecco, D. Delia, 2018, Cell Death & Differentiation.

Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice

M. Colombo, M. Rescigno, A. Stoppacciaro, 2005, Journal of Cell Science.

SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities

A. Sica, M. Colombo, C. Tripodo, 2019, Front. Immunol..

NEUTROPHIL EXTRACELLULAR TRAPS MEDIATE TRANSFER OF CYTOPLASMIC NEUTROPHIL ANTIGENS TO MYELOID DENDRITIC CELLS TOWARDS ANCA INDUCTION AND ASSOCIATED AUTOIMMUNITY RUNNING TITLE : NET / mDC cross-talk triggers autoimmunity

M. Colombo, S. Piconese, C. Tripodo, 2012 .

The matricellular protein SPARC supports follicular dendritic cell networking toward Th17 responses.

M. Colombo, R. Pedotti, V. Barnaba, 2011, Journal of autoimmunity.

Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies

M. Colombo, M. Dugo, C. Tripodo, 2014, Oncoimmunology.

Contributes to Mammary Carcinogenesis Production of Tumor Necrosis Factor That Critically Oncogene-Driven Intrinsic Inflammation Induces Leukocyte

G. Trinchieri, M. Colombo, S. Piconese, 2010 .

Oncogene-driven intrinsic inflammation induces leukocyte production of tumor necrosis factor that critically contributes to mammary carcinogenesis.

G. Trinchieri, M. Colombo, S. Piconese, 2010, Cancer research.

Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion.

S. Pileri, A. Carè, M. Colombo, 2012, Blood.

Amount of interleukin 12 available at the tumor site is critical for tumor regression.

M. Colombo, A. Stoppacciaro, C. Melani, 1996, Cancer research.

immune reactivity mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses Myeloid cell expansion elicited by the progression of spontaneous

M. Colombo, G. Forni, C. Melani, 2013 .

Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.

M. Colombo, G. Parmiani, C. Castelli, 1998, Journal of immunology.

Mechanisms for Tumor Killing and Use Fas / Fas Ligand-Independent CTL Clones Resist Fas Ligand-Induced Apoptosis + and CD 8 + Human Melanoma-Reactive CD 4

M. Colombo, G. Parmiani, C. Castelli, 1998 .

A Spatially Resolved Dark- versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B Cell Lymphomas

S. Pileri, A. Jeyasekharan, M. Colombo, 2020, iScience.

Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects.

M. Colombo, C. Tripodo, V. Longo, 2022, Cell reports.

CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress Conditions

N. Bolli, M. Colombo, C. Tripodo, 2021, Frontiers in Immunology.

CD40 provides immune privilege to the bone marrow hematopoietic niche

N. Bolli, M. Colombo, C. Tripodo, 2020, bioRxiv.

HIV/gp120 and PMA/ionomycin induced apoptosis but not activation induced cell death require PKC for Fas‐L upregulation

A. Carè, M. Colombo, M. Radrizzani, 1998, FEBS letters.

Matricellular proteins tune myeloid‐derived suppressor cell recruitment and function in breast cancer

M. Colombo, S. Sangaletti, C. Chiodoni, 2017, Journal of leukocyte biology.

Interferon g – independent Rejection of Interleukin 12 – transduced Carcinoma Cells Requires CD 4 1 T Cells and Granulocyte / Macrophage Colony – stimulating Factor

M. Colombo, N. Terrazzini, A. Stoppacciaro, 2010 .

Interferon (cid:103) –independent Rejection of Interleukin 12–transduced Carcinoma Cells Requires CD4 (cid:49) T Cells and Granulocyte/Macrophage Colony–stimulating Factor

M. Colombo, N. Terrazzini, A. Stoppacciaro, 1998 .

Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial–Stromal Tumors by Targeting PDGFR-β

M. Colombo, C. Tripodo, R. Tardanico, 2016, Molecular Cancer Therapeutics.

A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication.

Y. Ba, R. Xiang, He Zhou, 2005, Cancer research.

Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling

M. Colombo, M. Dugo, C. Tripodo, 2022, Molecular cancer.

In vivo manipulation of dendritic cell migration and activation to elicit antitumour immunity.

G. Trinchieri, M. Colombo, C. Caux, 2004, Novartis Foundation symposium.

Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer

V. Torri, Raghvendra Mall, G. Apolone, 2021, Cancer discovery.

IL‐1α gene‐transfected human melanoma cells increase tumor‐cell adhesion to endothelial cells and their retention in the lung of nude mice

P. Musiani, S. Bernasconi, M. Colombo, 1996 .

Nucleofection Is an Efficient Nonviral Transfection Technique for Human Bone Marrow–Derived Mesenchymal Stem Cells

M. Baccarani, M. Colombo, M. Aluigi, 2006, Stem cells.

A novel CXCR4 antagonist counteracts paradoxical generation of cisplatin-induced pro-metastatic niches in lung cancer

U. Pastorino, O. Fortunato, G. Sozzi, 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

SDF-1/CXCR4 inhibition prevents paradoxical generation of cisplatin-induced pro-metastatic niches

U. Pastorino, O. Fortunato, G. Sozzi, 2020, bioRxiv.

T Cells Expressing Receptor Recombination/Revision Machinery Are Detected in the Tumor Microenvironment and Expanded in Genomically Over-unstable Models

A. Bardelli, M. Colombo, G. Pruneri, 2021, Cancer Immunology Research.

Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis.

M. Colombo, R. Brekken, C. Rumio, 2008, Cancer research.

Impact of Immune Cell Heterogeneity on HER2+ Breast Cancer Prognosis and Response to Therapy

S. Sangaletti, C. Chiodoni, Milena Perrone, 2021, Cancers.

Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells.

M. Baccarani, M. Colombo, M. Aluigi, 2005, Experimental hematology.

Cancer immunotherapy based on killing of Salmonella-infected tumor cells.

Renato Longhi, Gordon Dougan, G. Dougan, 2005, Cancer research.

Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.

M. Colombo, A. Stoppacciaro, F. Liew, 2002, Cancer research.

CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin

P. Lollini, M. Colombo, P. Picci, 2014, Clinical Cancer Research.

Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis

M. Colombo, S. Sangaletti, C. Chiodoni, 2010, Cancer and Metastasis Reviews.

Common extracellular matrix regulation of myeloid cell activity in the bone marrow and tumor microenvironments

M. Colombo, C. Tripodo, S. Sangaletti, 2017, Cancer Immunology, Immunotherapy.

Ultrasound-guided intra-tumor injection of combined immunotherapy cures mice from orthotopic prostate cancer

M. Colombo, C. Tripodo, C. Chiodoni, 2013, Cancer Immunology, Immunotherapy.

Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal Remodeling.

P. Pandolfi, B. Falini, M. Colombo, 2017, Cancer research.

Immune Checkpoint Ligand Reverse Signaling: Looking Back to Go Forward in Cancer Therapy

M. Colombo, D. Lecis, S. Sangaletti, 2019, Cancers.

Elisabetta Vergani, Veronica Huber, Licia Rivoltini, 2016, Clinical Cancer Research.

Triggering CD40 on endothelial cells contributes to tumor growth

P. Musiani, M. Colombo, D. Granger, 2006, The Journal of experimental medicine.

Overview of the synergistic use of radiotherapy and immunotherapy in cancer treatment: current challenges and scopes of improvement

M. Colombo, M. D. De Santis, E. La Rocca, 2023, Expert review of anticancer therapy.

WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer

M. Iorio, A. Hidalgo-Miranda, C. Tripodo, 2019, Oncogene.

The good and bad of targeting cancer-associated extracellular matrix.

Claudio Tripodo, M. Colombo, C. Tripodo, 2017, Current opinion in pharmacology.

Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer

P. Lollini, M. Dugo, P. Nanni, 2016, Oncogene.

Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab.

M. Campiglio, S. Ménard, P. Lollini, 2014, Cancer research.

Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors

M. Colombo, C. Tripodo, C. Garofalo, 2017, Clinical Cancer Research.

Modulation of PD-1/PD-L1 axis in myeloid-derived suppressor cells by anti-cancer treatments.

M. Colombo, S. Sangaletti, R. Ferrara, 2021, Cellular immunology.

Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer

M. Colombo, C. Tripodo, P. Ostano, 2018, Cancer Immunology Research.

Interferon γ–independent Rejection of Interleukin 12–transduced Carcinoma Cells Requires CD4+ T Cells and Granulocyte/Macrophage Colony–stimulating Factor

M. Colombo, N. Terrazzini, A. Stoppacciaro, 1998, The Journal of Experimental Medicine.

Reversal of Tumor-induced Dendritic Cell Paralysis by CpG Immunostimulatory Oligonucleotide and Anti–Interleukin 10 Receptor Antibody

G. Trinchieri, M. Colombo, C. Caux, 2002, The Journal of experimental medicine.

Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy

C. Leonetti, M. Caraglia, M. Donadelli, 2018, Journal of Experimental & Clinical Cancer Research.

The Immune Landscape of Osteosarcoma: Implications for Prognosis and Treatment Response

C. Chiodoni, Caterina Cascini, 2021, Cells.

Infiltrating Mast Cell–Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype

M. Colombo, L. De Cecco, M. Dugo, 2020, Cancer Research.

ATF3 Reprograms the Bone Marrow Niche in Response to Early Breast Cancer Transformation

M. Colombo, B. Bassani, D. Lecis, 2022, Cancer research.

Different requirements for α‐galactosylceramide and recombinant IL‐12 antitumor activity in the treatment of C‐26 colon carcinoma hepatic metastases

M. Colombo, A. Stoppacciaro, S. Sangaletti, 2001, European journal of immunology.

SOCS2 Controls Proliferation and Stemness of Hematopoietic Cells under Stress Conditions and Its Deregulation Marks Unfavorable Acute Leukemias.

M. Colombo, L. De Cecco, P. Piccaluga, 2015, Cancer research.

Neutrophil extracellular traps arm DC vaccination against NPM-mutant myeloproliferation

M. Colombo, C. Tripodo, P. Comoli, 2021, bioRxiv.

Cell communication and signaling: how to turn bad language into positive one

C. Leonetti, M. Caraglia, M. Donadelli, 2019, Journal of Experimental & Clinical Cancer Research.

cIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cells

M. Colombo, L. De Cecco, D. Delia, 2018, Cell Death & Differentiation.

Cytokine gene transduction in tumor cells: interleukin (IL)-2 or IL-4 gene transfer in human melanoma cells.

M. Colombo, A. Anichini, J. Sulé-Suso, 1994, Natural immunity.

Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy

C. Leonetti, M. Caraglia, M. Donadelli, 2018, Journal of experimental & clinical cancer research : CR.

Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity.

M. Colombo, S. Piconese, C. Tripodo, 2012, Blood.

ZEB1 shapes AML immunological niches suppressing CD8 T-cell activity while fostering Th17 cell expansion

N. Bolli, M. Colombo, C. Tripodo, 2023, bioRxiv.

A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancer

M. Colombo, G. Pruneri, L. De Cecco, 2023, ESMO open.

Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma

M. Colombo, C. Tripodo, C. Meazza, 2023, Journal of Experimental & Clinical Cancer Research.